Most recently, it has been discovered that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in identical parts as classical opioid receptors, it binds to some wide array of endogenous opioids. Not like most opioid receptors, this receptor functions like a scavenger and won't activate a 2nd mess… Read More